Sanofi has agreed another deal to flesh out its R&D pipeline, paying IGM Biosciences $150 million upfront to gain access to its engineered IgM antibody technology across six targets in oncology and ...
The rodeo arena will host from 1,100 people to 1,400 people. The Phase One funding will be covered by state funds, and will cost roughly $1.3 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback